Pipeline
FOCUS AREA CANDIDATES
TARGET
Research
IND-enabling
Phase 1
Phase 2/3
IMMUNOLOGICAL AND DEGENERATIVE DISEASES
EI-1071Alzheimer's disease; Tenosynovial Giant Cell Tumors
CSF1R
small molecule inhibitorPHASE 1
EI-001Chronic Hepatitis B
Undisclosed
antibodyIND-ENABLING
CANCER
EI-1071Multiple indication options
CSF1R
small molecule inhibitorIND-ENABLING
EI-003Multiple indication options
CSF1R
bifunctionalRESEARCH
EI-011Multiple indication options
PDL-1
bifunctionalRESEARCH
EI-012Multiple indication options
Treg cells
antibodyRESEARCH
EI-014Hepatocellular carcinoma
VEGF/PDL-1
bispecificRESEARCH
